Business Context and Reporting Period
Pacific Biosciences of California, Inc. filed this Form 8-K to report the results of its Annual Meeting of stockholders held on May 22, 2014.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes
No material financial changes or operational updates are reported in this filing. The document solely details the outcomes of shareholder votes.
Management Commentary and Voting Results
The following matters were submitted to a vote of security holders:
- Proposal 1: Election of Class I Directors
- Brook Byers: Elected (37,398,573 For; 1,605,886 Withheld)
- John Milligan, Ph.D.: Elected (38,405,717 For; 598,742 Withheld)
- Lucy Shapiro, Ph.D.: Elected (32,734,582 For; 6,269,877 Withheld)
- Proposal 2: Advisory Approval of Executive Compensation
- Approved (38,432,059 For; 323,942 Against; 248,458 Abstain)
- Proposal 3: Ratification of Independent Auditor
- Ernst & Young LLP was ratified for the fiscal year ending December 31, 2014 (56,872,277 For; 29,020 Against; 64,261 Abstain)
Investor Verification Checklist
- Verify the election of the three Class I Directors as reported.
- Confirm the advisory approval of executive compensation.
- Note the ratification of Ernst & Young LLP as the independent auditor.
- Refer to the company's most recent 10-K or 10-Q for financial performance data, as this 8-K contains no financial metrics.